PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Komajda, Michel
TI  - Ivabradine Added to Standard Therapy Improves Outcomes in Patients with Systolic HF
DP  - 2010 Dec 01
TA  - MD Conference Express
PG  - 10--11
VI  - 10
IP  - 8
4099  - http://mdc.sagepub.com/content/10/8/10.2.short
4100  - http://mdc.sagepub.com/content/10/8/10.2.full
AB  - Results of the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial [SHIFT; ISRCTN70429960] indicate that when added to standard therapy, ivabradine reduced heart rate and improved outcomes in subjects with systolic heart rate as early as 3 months [Swedberg K et al. Lancet 2010].